Conference abstract
Research articlePublished 2013
Statistical Considerations in Biosimilar Assessment Using Biosimilarity Index
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
When an innovative biologic product goes off patent, biopharmaceutical or biotechnological companies may file an application for regulatory approval of biosimilar products. Unlike small molecule drug products, biosimilars are not exact copies of their brand-name counterpart, and they are usually very sensitive to changes in environmental factors and have greater variabilities due to their complexity and sensitivity to variation in manufacturing processes. Facing these challenges, a biosimilarity index based on reproducibility probability is proposed to assess biosimilarity. In this article, we have demonstrated how to assess biosimilarity between the test and reference product in relative to a reference standard that is established in a study where reference product is compared with itself. Biosimilairty index approach is robust against biosimilarity criteria and has the advantage of allowing the assessment of the degree of similarity.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Research article · 2014
Statistical Designs for Assessing Interchangeability of Biosimilar Products
Conference abstract
Regulatory consideration of the assessment of biosimilar products
Conference abstract · 28 Apr 2021
Analytical Similarity Assessment of Bevacizumab Biosimilar Candidate MB02 Using Multiple State-of-the-art Assays
Editorial · 2014
On Assessment of Analytical Similarity in Biosimilar Studies
More from this journal
The newest in Journal of Bioequivalence & Bioavailability.
Article · 5 Oct 2026
Long COVID in pediatric and young adult patients: a review of evaluation for microvascular changes, endothelial dysfunction, and arterial stiffness
Article · 12 Jun 2026
Advances in Bioavailability Through Innovative Drug Delivery Systems and Formulation Technologies
Article · 12 Jun 2026
Bioequivalence Study Design and Methodological Approaches in Generic Drug Evaluation
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Bioequivalence & Bioavailability
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Aijing Zhang”
- BylineArticles whose byline prints “Jung-Ying Tzeng”
- BylineArticles whose byline prints “Shein-Chung Chow”
